This company has been marked as potentially delisted and may not be actively trading. Cyclo Therapeutics (CYTH) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cyclo Therapeutics (NASDAQ:CYTH)CurrentInstitutional OwnershipPercentage68.55%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$25.10KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$29.49K Get CYTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Cyclo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CYTH Institutional Buying and Selling by Quarter Cyclo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 Two Sigma Securities LLC42,541$25K0.0%N/A0.148% 2/7/2025EPIQ Capital Group LLC689,447$407K0.1%-6.8%2.396% 8/10/2024EPIQ Capital Group LLC817,270$1.04M0.4%-4.3%2.856% 2/15/2024 Founders Fund V Management LLC480,708$764K80.8%N/A2.115% 2/15/2024 Founders Fund VI Management LLC110,023$175K1.4%N/A0.484% 11/9/2021BlackRock Inc.13,134$88K0.0%+21.1%0.204% 8/16/2021 State Street Corp44,700$457K0.0%N/A0.703% 8/13/2021 Geode Capital Management LLC42,577$435K0.0%+133.2%0.670% 8/13/2021 Vanguard Group Inc.151,540$1.55M0.0%+350.4%2.383% (Data available from 1/1/2016 forward) CYTH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CYTH shares? During the previous two years, the following institutional investors and hedge funds held shares of Cyclo Therapeutics shares: Founders Fund V Management LLC ($764K), EPIQ Capital Group LLC ($407K), and Founders Fund VI Management LLC ($175K), Two Sigma Securities LLC ($25K).Learn more on Cyclo Therapeutics' institutional investors. What percentage of Cyclo Therapeutics' stock is owned by institutional investors? 68.55% of Cyclo Therapeutics' stock is owned by institutional investors. Learn more on CYTH's institutional investor holdings. Which institutional investors have been buying Cyclo Therapeutics' stock? The following institutional investors have purchased Cyclo Therapeutics' stock in the last 24 months: Founders Fund V Management LLC ($480.71K), Founders Fund VI Management LLC ($110.02K), and Two Sigma Securities LLC ($42.54K). How much institutional buying is happening at Cyclo Therapeutics? Institutional investors have bought a total of 42,541 shares in the last 24 months. This purchase volume represents approximately $25.10K in transactions. Which of Cyclo Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Cyclo Therapeutics stock in the last 24 months: EPIQ Capital Group LLC ($49.98K). How much institutional selling is happening at Cyclo Therapeutics? Institutional investors have sold a total of 49,979 shares in the last 24 months. This volume of shares sold represents approximately $29.49K in transactions. Related Companies CELU Major Shareholders OVID Major Shareholders CRDL Major Shareholders ORMP Major Shareholders CRVO Major Shareholders OKYO Major Shareholders ENTX Major Shareholders VXRT Major Shareholders QNCX Major Shareholders ATRA Major Shareholders This page (NASDAQ:CYTH) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTH Stock Alerts